MEDICASAFE, INC.

Medtech · Private

MedicaSafe BNT: a device and software platform that delivers buprenorphine/naloxone with adherence tracking to improve patient compliance in opioid use disorder treatment.

Grants
$1.4M
4 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
15
10 granted · 5 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Implicit Cognition Assessments for Risk of Prescription Opioid Abuse$140,003
Federal grantDepartment of Health and Human Services · Phase I · Technology-Guided Opioid Cessation for Post-Operative Pain$243,321
Federal grantDepartment of Health and Human Services · Phase II · Enhanced Treatment Management of Opioid-Dependence in an Office-Based Setting$491,331
Federal grantDepartment of Health and Human Services · Phase II · Enhanced Treatment Management of Opioid-Dependence in an Office-Based Setting$499,619
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1719FHC, INC.——
1720VOLTMED, INC.——
1721QUANTUMMED INC——
1722MEDICASAFE, INC.——
1723George Dodge——
1724NITINETICS, LLC——
1725WAVI COMPANY——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 10 granted of 15

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.